Literature DB >> 11241061

Ophthalmic drops causing coma in an infant.

R J Berlin1, U T Lee, J R Samples, L F Rich, D D Tang-Liu, K A Sing, R D Steiner.   

Abstract

A 1-month-old infant with Peters anomaly had recurrent episodes of unresponsiveness, hypotension, hypotonia, hypothermia, and bradycardia. An extensive medical evaluation determined these episodes to be caused by brimonidine, an anti-glaucoma agent. There is the potential for serious toxic effects from the systemic absorption of topically applied ophthalmic agents in children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241061     DOI: 10.1067/mpd.2001.111319

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Charles Bonnet syndrome precipitated by brimonidine tartrate eye drops.

Authors:  R L Tomsak; C R Zaret; D Weidenthal
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

Review 2.  Formulations for children: problems and solutions.

Authors:  Hannah K Batchelor; John F Marriott
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 3.  [Possibilities and limitations of eye drops for glaucoma therapy].

Authors:  I M Lanzl; M Poimenidou; G L Spaeth
Journal:  Ophthalmologe       Date:  2016-10       Impact factor: 1.059

4.  [Depression of respiration via toxic effects on the central nervous system following use of topical brimonidine in an infant with congenital glaucoma].

Authors:  K Heimann; T Peschgens; U Merz; H Hoernchen; T Wenzl
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

5.  Brimonidine in the treatment of glaucoma and ocular hypertension.

Authors:  Louis B Cantor
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.